NM_000093.5:c.4126dupT
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000093.5(COL5A1):c.4126dupT(p.Ser1376PhefsTer7) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. S1376S) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000093.5 frameshift
Scores
Clinical Significance
Conservation
Publications
- Ehlers-Danlos syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome, classic typeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, PanelApp Australia, Genomics England PanelApp
- Ehlers-Danlos syndrome, classic type, 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- arterial disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| COL5A1 | NM_000093.5 | c.4126dupT | p.Ser1376PhefsTer7 | frameshift_variant | Exon 53 of 66 | ENST00000371817.8 | NP_000084.3 | |
| COL5A1 | NM_001278074.1 | c.4126dupT | p.Ser1376PhefsTer7 | frameshift_variant | Exon 53 of 66 | NP_001265003.1 | ||
| COL5A1 | XM_017014266.3 | c.4126dupT | p.Ser1376PhefsTer7 | frameshift_variant | Exon 53 of 65 | XP_016869755.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| COL5A1 | ENST00000371817.8 | c.4126dupT | p.Ser1376PhefsTer7 | frameshift_variant | Exon 53 of 66 | 1 | NM_000093.5 | ENSP00000360882.3 | ||
| COL5A1 | ENST00000371820.4 | c.4126dupT | p.Ser1376PhefsTer7 | frameshift_variant | Exon 53 of 66 | 2 | ENSP00000360885.4 | 
Frequencies
GnomAD3 genomes  
GnomAD4 exome Cov.: 32 
GnomAD4 genome  
ClinVar
Submissions by phenotype
not provided    Pathogenic:1 
Although the c.4126dupT pathogenic variant in the COL5A1 gene has not been reported to our knowledge, this variant causes a shift in reading frame starting at codon Serine 1376, changing it to a Phenylalanine, and creating a premature stop codon at position 7 of the new reading frame, denoted p.Ser1376PhefsX7. This pathogenic variant is expected to result in either an abnormal, truncated protein product or loss of protein from this allele through nonsense-mediated mRNA decay. Multiple other frameshift variants in the COL5A1 gene have been reported in the Human Gene Mutation Database in association with classical Ehlers-Danlos syndrome (cEDS, EDS type I and II) (Stenson et al., 2014), indicating that loss of function is a mechanism of disease for this gene. Furthermore, the c.4126dupT variant has not been observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). -
Ehlers-Danlos syndrome, classic type, 1    Pathogenic:1 
Loss-of-function variants in COL5A1 are known to be pathogenic (PMID: 23587214). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with COL5A1-related disease. ClinVar contains an entry for this variant (Variation ID: 430182). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Ser1376Phefs*7) in the COL5A1 gene. It is expected to result in an absent or disrupted protein product. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at